Medindia LOGIN REGISTER
Medindia

Revolutionizing ENT Infection Diagnosis With Microbial Cell-Free DNA

Listen to this article
0:00/0:00

Microbial cell-free DNA (mcfDNA) testing offers a quicker, less invasive method to identify ENT infections in children, potentially optimizing antibiotic use and reducing healthcare costs.

Revolutionizing ENT Infection Diagnosis With Microbial Cell-Free DNA
Microbial cell-free DNA (mcfDNA) testing shows the potential to offer a less invasive and faster alternative to identify microbial infections in the ear, nose, and throat (ENT) (1 Trusted Source
Efficacy of microbial cell-free DNA testing for detecting pathogens in pediatric patients with head and neck infections-An initial study

Go to source
).
ENT infections can be identified and diagnosed easily in children and are mostly prescribed with antibiotics. However, severe infections require clinicians to collect and analyze samples using surgical procedures and traditional culturing methods.

These methods are time-consuming to find the results and doctors prescribe broad-spectrum antibiotics to treat the condition in the meantime. This increases healthcare costs and complications such as hospital-derived infections in children. Therefore, a fast diagnostic assay would help clinicians identify pathogens quickly and allow for better and more timely clinical interventions in pediatric patients.

mcfDNA Testing for Kids' Head and Neck Infections

Recent studies in this field have indicated mcfDNA testing as a viable assay capable of identifying pathogens from the bloodstream. However, this technique has not been studied for use in severe infections of the head and neck regions in children.

To fill this gap, a group of researchers led by Assistant Professor Kara Meister from the Stanford University School of Medicine, USA, studied the utility of mcfDNA testing in predicting causative organisms behind head and neck infections in children. Their findings were published online on January 6, 2025, in Pediatric Investigation. Dr. Meister explains the rationale behind their study, “The head and neck area has several highly vascularized regions such as the sinonasal cavity and the oropharynx. Therefore, we anticipate that significant infections in these regions will produce enough mcfDNA signal to be detectable on commercial testing.”

The researchers conducted a prospective, diagnostic study on 26 pediatric patients admitted at the Lucile Packard Children’s Hospital, suspected with acute and complex infections of the head and neck. 2.5 milliliters of blood from each patient was submitted for mcfDNA testing. A control population of 99 patients was also selected who were admitted for surgical procedures, not for infections such as cochlear implants. “The primary objective of this study was to examine the diagnostic performance of mcfDNA testing as compared with microbiological and clinical data including conventional microbiological diagnostic tests, radiological studies, and clinical adjudication,” Dr. Meister offers to explain the main goal of their study.

Accuracy of mcfDNA Testing in Children

The results from mcfDNA testing were classified as ‘Consistent with infection’, ‘Unclear’, ‘Not consistent with clinical presentation’, or ‘Contaminant’. The researchers found that in seven out of 26 patients (26.9%), the mcfDNA testing predicted infectious organisms consistent with that of traditional culturing tests. These patients had acute, invasive infections, with most of them not being exposed to antibiotics at the time of testing. However, in two out of 26 patients (7.7%), a possible causal organism was identified via mcfDNA testing but the findings differed from that of traditional culturing tests. In these cases, the identity of the causative organism was unclear.

Advertisement
For 10 patients no results were found from mcfDNA testing, and were classified under ‘Not consistent with clinical presentation’. Five of these patients had prior antibiotic exposure and had less severe infections. However, in seven out of 26 patients (26.9%), mcfDNA testing showed significant contamination by other pathogens and was classified as a ‘contaminant’ result. Interestingly, the researchers reported that some patients in the control population also showed results for mcfDNA tests. They were able to detect 25 distinct pathogens from the control population.

Dr. Meister comments on the results of their study, “Overall, while mcfDNA testing showed promise in predicting causative organisms in some cases of acute, invasive infections, its utility was variable in this cohort and was potentially influenced by factors such as antibiotic exposure and the possible influence of contamination.”

Advertisement
While further research is required to evaluate the optimal use and interpretation of mcfDNA tests, this study sheds light on the potential application of mcfDNA testing for detecting specific pathogens leading to targeted antibiotic therapies in pediatric patients.

Reference:
  1. Efficacy of microbial cell-free DNA testing for detecting pathogens in pediatric patients with head and neck infections—An initial study - (https://onlinelibrary.wiley.com/doi/10.1002/ped4.12462)


Source-Eurekalert


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional